Lilly Asia Ventures I Overview

  • Fund Type
  • Venture

  • Fund Status
  • Closed

  • Size

  • Vintage
  • 2007

Vintage

  • Dry Powder

Lilly Asia Ventures I General Information

Description

Lilly Asia Ventures I is a venture capital fund managed by Lilly Asia Ventures. The fund is located in Hong Kong, Hong Kong and invests in China. The fund targets investments in the pharmaceutical, biotechnology, life science and oncology sectors. The fund prefers minority stake. The fund investment amount ranges from USD 5 million to USD 15 million.

Contact Information

Fund Manager
Fund Manager Website
Fund Category
Venture Capital
Close Date
Fund Family
LAV Biosciences Fund
Native Currency
USD
Fund Manager's Location
  • Room 606, St. George's Building
  • 2 Ice House Street
  • Hong Kong
  • Hong Kong
+852 2303
Fund Domiciles
Cayman Islands
China

Lilly Asia Ventures I Investments (12)

Lilly Asia Ventures I has made a total of 12 investments. Its most recent deal was a with Structure Therapeutics for . The deal was made on 01-Aug-2022.

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Structure Therapeutics 01-Aug-2022 Drug Discovery Clinical Trials - Phase 1
Betta Pharmaceuticals 07-Nov-2016 Pharmaceuticals Profitable
3Sbio 30-May-2013 Pharmaceuticals Profitable
Innovent Biologics 16-Nov-2012 Pharmaceuticals Startup
Novast 12-Jun-2012 Pharmaceuticals Generating Revenue
BrightGene Bio-Medical Technology Company 20-Mar-2011 Biotechnology Generating Revenue
CITIC Pharmaceuticals 01-Mar-2010 Medical Supplies Generating Revenue
Betta Pharmaceuticals 01-Jan-2010 Pharmaceuticals Generating Revenue
Novast 03-Jul-2009 Later Stage VC (Series C) Pharmaceuticals Generating Revenue
Chipscreen 01-Jan-2009 Later Stage VC (Series B) Drug Discovery Generating Revenue
You’re viewing 10 of 12 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Lilly Asia Ventures I Investment Strategy

Investments by Industry

Investments by Deal Type

PitchBook helps you see a fund’s investments based on target industry, year and deal type—so you can quickly understand its strategy at a glance.

Request a free trial

Lilly Asia Ventures I Returns Data

The below charts are illustrative of the type of graphical data available to our clients and do not represent live data.

IRR (%)

 

DPI (x)

 

RVPI (x)

 

TVPI (x)

 

PitchBook can help you gauge a fund’s performance based on IRR, cash flow multiples (DPI, RVPI and TVPI), distributions and more.

Request a free trial

Lilly Asia Ventures I FAQs

  • What is Lilly Asia Ventures I?

    Lilly Asia Ventures I is a venture capital fund managed by Lilly Asia Ventures.

  • Who manages Lilly Asia Ventures I?

    Lilly Asia Ventures I is managed by Lilly Asia Ventures.

  • Where is Lilly Asia Ventures I domiciled?

    Lilly Asia Ventures I is domiciled in Cayman Islands and China.

  • What is Lilly Asia Ventures I's size?

    Lilly Asia Ventures I has a size of .

  • What type of fund is Lilly Asia Ventures I?

    The fund type of Lilly Asia Ventures I is Venture.

  • What is the status of Lilly Asia Ventures I?

    Lilly Asia Ventures I is closed.

  • What has Lilly Asia Ventures I invested in?

    Lilly Asia Ventures I has made numerous investments in companies like Structure Therapeutics, Betta Pharmaceuticals, and 3Sbio within the Drug Discovery and Pharmaceuticals industries.

  • What has Lilly Asia Ventures I invested in recently?

    Lilly Asia Ventures I's latest investment was on 01-Aug-2022 in Structure Therapeutics, a company within the Drug Discovery industry.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »